-
May 2, 2022 Elon Musk Excites Psychedelic Industry CEOs with This TweetThis is one of the billionaire's most explicit acknowledgments of the power of psychedelics for...
-
April 29, 2022 Why Field Trip Health Is Dividing in Two — and What This Means for InvestorsField Trip Health plans to split into two independent, publicly traded companies: Field Trip Health...
-
April 14, 2022 3 Most Promising Psychedelics for Mental Health BreakthroughsPsychiatrist, researcher, and CEO of Zylorion Health, Dr. Peter Silverstone, ranks psychedelic medicines based on...
-
March 30, 2022 5 Most Important Psychedelic Clinical Trials in 2022Here's why we think MAPS’ second Phase 3 MDMA trial is the most important psychedelic...
-
March 23, 2022 Ketamine Study Suggests the Psychedelic Could Treat Parkinson’s DiseasePharmaTher evaluates safety, tolerability and efficacy of low-dose ketamine infusion for treatment of LID in...
-
March 18, 2022 Psychedelic Business Spotlight – March 18This week in psychedelic business news: A psychedelics company folds; Ketamine Wellness Centers expand; Nova...
-
March 15, 2022 Top 5 Most Influential Psychedelic StudiesWe unpack five of the most important psychedelic studies conducted in recent years as psychedelics...
-
March 1, 2022 Dr. Bronner’s Magic Soaps Offers Free Ketamine-Assisted Therapy to Employees"Considering all our advocacy on this issue, this employee benefit is the next logical step,"...
-
February 25, 2022 Psychedelic Business Spotlight – February 25This week in psychedelic business news: Core One cheapens psilocybin production; Field Trip eyes Oregon;...
-
February 24, 2022 Interview with Dr. Erica ZelfandThis week on the Psychedelic Spotlight podcast, we're chatting with Dr. Erica Zelfand. She is...
